26 related articles for article (PubMed ID: 6155751)
1. Coffee consumption and risk of fractures: a meta-analysis.
Liu H; Yao K; Zhang W; Zhou J; Wu T; He C
Arch Med Sci; 2012 Nov; 8(5):776-83. PubMed ID: 23185185
[TBL] [Abstract][Full Text] [Related]
2. Caffeine does not cause in vitro calcium loss from neonatal mouse calvaria.
Bergman EA; Newbrey JW; Massey LK
Calcif Tissue Int; 1988 Nov; 43(5):281-3. PubMed ID: 3145793
[TBL] [Abstract][Full Text] [Related]
3. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
Lerner UH; Fredholm BB; Ransjö M
Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
[TBL] [Abstract][Full Text] [Related]
4. Cyclic nucleotides and the rapid inhibitions of bone 45Ca uptake in response to bovine parathyroid hormone and 16,16-dimethyl prostaglandin E2 in chicks.
Shaw AJ; Dacke CG
Calcif Tissue Int; 1989 Mar; 44(3):209-13. PubMed ID: 2465812
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 interacts synergistically with forskolin and isobutylmethylxanthine in stimulating bone resorption in organ culture.
Dewhirst FE; Ago JM; Stashenko P
Calcif Tissue Int; 1990 Jul; 47(1):1-7. PubMed ID: 1695117
[TBL] [Abstract][Full Text] [Related]
6. Caffeine has the capacity to stimulate calcium release in organ culture of neonatal mouse calvaria.
Lerner UH; Mellström D
Calcif Tissue Int; 1992 Dec; 51(6):424-8. PubMed ID: 1451009
[TBL] [Abstract][Full Text] [Related]
7. Skeletal actions of parathyroid hormone.
Wong G
Miner Electrolyte Metab; 1982; 8(3-4):188-98. PubMed ID: 6300630
[No Abstract] [Full Text] [Related]
8. Parathyroid hormone and bone.
Reeve J; Zanelli JM
Clin Sci (Lond); 1986 Sep; 71(3):231-8. PubMed ID: 3530605
[No Abstract] [Full Text] [Related]
9. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
Lerner U; Ransjö M; Fredholm BB
Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
[TBL] [Abstract][Full Text] [Related]
10. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
Lerner U; Gustafson GT
Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
Lerner UH; Ransjö M; Ljunggren O
Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
[TBL] [Abstract][Full Text] [Related]
12. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
Ransjö M; Fredholm BB; Lerner UH
Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
[TBL] [Abstract][Full Text] [Related]
13. Delayed stimulatory effect of cyclic AMP on bone resorption in vitro.
Lerner U; Gustafson GT
Acta Endocrinol (Copenh); 1981 Jun; 97(2):281-8. PubMed ID: 6165208
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of bone resorption and lysosomal enzyme release from calvarial bones cultured for 24 hours: synergism between cyclic AMP analogues and phosphodiesterase inhibitors.
Lerner U
Acta Endocrinol (Copenh); 1980 May; 94(1):138-44. PubMed ID: 6155751
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
